Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCD | Q05655 | 7/20 | 0.63 |
| ▸ | PRKACA | P17612 | 6/20 | 0.63 |
| ▸ | PRKD3 | O94806 | 6/20 | 0.63 |
| ▸ | PRKCZ | Q05513 | 6/20 | 0.63 |
| ▸ | PRKACG | P22612 | 5/20 | 0.63 |
| ▸ | PRKACB | P22694 | 5/20 | 0.63 |
| ▸ | PRKCG | P05129 | 5/20 | 0.63 |
| ▸ | PRKCB | P05771 | 5/20 | 0.63 |
| ▸ | PRKCA | P17252 | 5/20 | 0.63 |
| ▸ | PRKCH | P24723 | 5/20 | 0.63 |
| ▸ | PRKCI | P41743 | 5/20 | 0.63 |
| ▸ | PRKCE | Q02156 | 5/20 | 0.63 |
| ▸ | PRKCQ | Q04759 | 5/20 | 0.63 |
| ▸ | PRKD1 | Q15139 | 5/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL567639 | 1.00 | PRKCD (0.63) | PRKCDPRKACAPRKD3PRKCZPRKACG | |
| Hydrochloric Acid SCHEMBL566273 | 0.99 | PRKCD (0.64) | PRKCDPRKACAPRKD3PRKCZPRKACG | |
| Hydrochloric Acid SCHEMBL566274 | 0.99 | PRKCD (0.64) | PRKCDPRKACAPRKD3PRKCZPRKACG | |
| SCHEMBL566375 | 0.97 | PRKCD (0.64) | PRKCDPRKACAPRKD3PRKCZPRKACG | |
| SCHEMBL566374 | 0.97 | PRKCD (0.64) | PRKCDPRKACAPRKD3PRKCZPRKACG | |
| SCHEMBL567445 | 0.97 | PRKCD (0.64) | PRKCDPRKACAPRKD3PRKCZPRKACG | |
| Hydrochloric Acid SCHEMBL567555 | 0.96 | PRKCD (0.65) | PRKCDPRKACAPRKD3PRKCZPRKACG | |
| Hydrochloric Acid SCHEMBL567556 | 0.96 | PRKCD (0.65) | PRKCDPRKACAPRKD3PRKCZPRKACG | |
| Hydrochloric Acid SCHEMBL568137 | 0.96 | PRKCD (0.65) | PRKCDPRKACAPRKD3PRKCZPRKACG | |
| SCHEMBL567614 | 0.86 | PRKCD (0.59) | PRKCDPRKACAPRKD3PRKCZPRKACG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2444395-B1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | WESTERN THERAPEUTICS INST INC D (JP) | 2016-01-06 | — | — | EP | claimed |
| US-8951997-B2 | Substituted isoquinoline derivative | D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) | 2015-02-10 | — | — | US | claimed |
| EP-2444395-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | D. Western Therapeutics Institute, Inc. (JP) | 2012-04-25 | — | — | EP | claimed |
| US-20120035159-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | D. WESTERN THERAPEUTICS INSTITUTE, INC (JP) | 2012-02-09 | — | — | US | claimed |
| EP-2444395-B1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | WESTERN THERAPEUTICS INST INC D (JP) | 2016-01-06 | — | — | EP | disclosed |
| EP-2444395-B1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | WESTERN THERAPEUTICS INST INC D (JP) | 2016-01-06 | — | — | EP | disclosed |
| US-8951997-B2 | Substituted isoquinoline derivative | D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) | 2015-02-10 | — | — | US | disclosed |
| US-8951997-B2 | Substituted isoquinoline derivative | D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) | 2015-02-10 | — | — | US | disclosed |
| EP-2444395-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | D. Western Therapeutics Institute, Inc. (JP) | 2012-04-25 | — | — | EP | disclosed |
| EP-2444395-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | D. Western Therapeutics Institute, Inc. (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-20120035159-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | D. WESTERN THERAPEUTICS INSTITUTE, INC (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120035159-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | D. WESTERN THERAPEUTICS INSTITUTE, INC (JP) | 2012-02-09 | — | — | US | disclosed |
| WO-2010146881-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | 株式会社デ・ウエスタン・セラピテクス研究所 (JP) | 2010-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035159-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | SULT1A1, SULT1E1, SULT2A1 | PRKCD 3122/4885PRKACA 4256/4885PRKD3 1746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.